ImportRefusal LogoImportRefusal

Cipla Ltd

⚠️ Moderate Risk

FEI: 3004132697 • Goa, 4 • INDIA

FEI

FEI Number

3004132697

📍

Location

Goa, 4

🇮🇳

Country

INDIA
🏢

Address

352 Kundaim Industrial Estate, , Goa, 403115, India

Moderate Risk

FDA Import Risk Assessment

44.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
1
Unique Violations
4/26/2012
Latest Refusal
10/10/2008
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
11.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
4/26/2012
62ODA14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/26/2012
60XCA17ATENOLOL (ANTI-ADRENERGIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/5/2011
66SCA51TADALAFIL
75UNAPPROVED
New Orleans District Office (NOL-DO)
10/10/2008
62OCB25DILTIAZEM MALATE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Cipla Ltd's FDA import refusal history?

Cipla Ltd (FEI: 3004132697) has 4 FDA import refusal record(s) in our database, spanning from 10/10/2008 to 4/26/2012.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Cipla Ltd's FEI number is 3004132697.

What types of violations has Cipla Ltd received?

Cipla Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Cipla Ltd come from?

All FDA import refusal data for Cipla Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.